Warning: Creating default object from empty value in /home/adhdmed/public_html/wp-content/themes/canvas/functions/admin-hooks.php on line 160

Venvanse Accepted For European Review

Venvanse in EuropeShire’s once daily ADHD medication Venvanse (know as Vyvanse in the USA and Canada) has been accepted for review by UK regulator, the MHRA. This is the first step for this medication to gain entry into Europe. In fact, this would be the first amphetamine based ADHD medication in Europe. While most European countries have Methylphenidate medications (such as Ritalin and Concerta) and the non-stimulant Atomoxetine (Strattera), they do not have any of the amphetamine based medications which are available in other countries (such as Adderall, Adderall XR, Vyvanse and Dexedrine).

This news was reported on January 6, 2012. It is not clear how long the review will take, and when Venvanse will actually become available in the UK, and other European countries.

You can read the original news story here.

About Dr. Kenny Handelman

Dr. Kenny Handelman is a Canadian Psychiatrist, expert in ADD/ADHD, and the author of Attention Difference Disorder.

, , ,

No comments yet.

Leave a Reply